antigen retrieval (Proteintech)
Proteintech is a verified supplier 
96
Structured Review
Proteintech
antigen retrieval
Antigen Retrieval, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 460 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pax8+antibody/PAX8+Antibody/pm41845519-76-18-22
Average 96 stars, based on 460 article reviews
Antigen Retrieval, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 460 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pax8+antibody/PAX8+Antibody/pm41845519-76-18-22
Average 96 stars, based on 460 article reviews
antigen retrieval - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Expressing:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: In Vivo:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Staining:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Immunohistochemistry:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Quantitative RT-PCR:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Immunohistochemical staining:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Western Blot:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Generated:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Genetically Modified:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Immunofluorescence:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Irradiation:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Fluorescence:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Injection:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Control:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Phospho-proteomics:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Cell Culture:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Marker:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Recombinant:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Polymer:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: CRISPR:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Plasmid Preparation:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Software:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Incubation:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: Amplification:Article Title: Thyroid Hormone Receptor α1: A Novel Regulator of Thyroid Cancer Cell Differentiation Article Snippet: Anti-Ki-67 (cell signaling technology, Massachusetts, MA), cleaved caspase-3 (cell signaling technology, Massachusetts, MA), and Article Title: Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer Article Snippet: Antibodies and their dilutions used for western blotting were pRPA32 (S4/S8) (Bethyl Labs; A300–245A; 1:2500), pRPA32 (S33) (Bethyl Labs; A300–246A; 1:2500), Article Title: An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time. Article Snippet: Primary ovarian cancer cells were seeded in 24-well plates at a density of 5 3 102 cells per well for staining of pan-CK (Invitrogen, 1:100 dilution) or Article Title: Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer Article Snippet: The following primary antibodies were used: Article Title: Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulation. Article Snippet: The following antibodies were used to characterize patient’s derived Tumour Organoid K. Asif et al. Biomedicine & Pharmacotherapy 171 (2024) 116017 and parent tumour: |